ISSN : 0976-4887
EISSN : 0976-4895
Gomase V.S.1*, Parundekar A.N.2
1School of Technology, S.R.T.M. University, Sub-Centre, Latur, 413531
2Padmashree Dr. D. Y. Patil University, CBD Belapur, Navi Mumbai, 400614, India
* Corresponding Author : gomase.viren@gmail.com
Received : - Accepted : - Published : 15-06-2010
Volume : 1 Issue : 1 Pages : 12 - 24
Int J Genom Proteomics 1.1 (2010):12-24
DOI : http://dx.doi.org/10.9735/0976-4887.1.1.12-24
Conflict of Interest : None declared
[1] Lang K, Entschladen F, Weidt C, Zaenker KS.[ 2006] Tumor immune escape mechanisms:
impact of the neuroendocrine system. Cancer Immunol Immunother.55[7]:749-60
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[2] Botti C, Seregni E, Ferrari L, Martinetti A, Bombardieri E.[1998] Immunosuppressive factors:
role in cancer development and progression. Int J Biol Markers. 13[2]:51-69
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[3] M.J. Garlepp, C.C. Leong[1995,] Biological and immunological aspects of malignant
mesothelioma Eur Respir J, 8, 643–650
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[4] Chakraverty R, Sykes M.[ 2007] The role of antigen-presenting cells in triggering graftversus-
host disease and graft-versus-leukemia. Blood110[1]:9-17
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[5] Detours V, Perelson AS.[2000] The paradox of alloreactivity and self MHC restriction:
quantitative analysis and statistics. Proc Natl Acad Sci U S A. 97[15]:8479-83
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[6] Nesic D, Maric M, Santori FR, Vukmanovic S[2002]. Factors influencing the patterns of T
lymphocyte allorecognition. Transplantation.73 [5]:797-803.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[7] Hornell TM, Myers N, Hansen TH, Connolly JM.[2003] Homology between an alloantigen
and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire
independent of TCR affinity. J Immunol. 170[9]:4506-14.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[8] Whitelegg A, Barber LD.[2004] The structural basis of T-cell allorecognition. Tissue
Antigens.63[2]:101-8
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[9] Slavin S.[2002] Maternal-fetal relationship, natural chimerism and bilateral transplantation
tolerance as the basis for non-myeloablative stem cell transplantation. Int J Hematol. 76
Suppl 1:172-5
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[10] Erikci AA, Karagoz B, Ozyurt M, Ozturk A, Kilic S, Bilgi O.[2009] HLA-G expression in B
chronic lymphocytic leukemia: a new prognostic marker? Hematology,14[2]:101-5
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[11] Feng X, Hui KM, Younes HM, Brickner AG.[2008] Targeting minor histocompatibility
antigens in graft versus tumor or graft versus leukemia responses. Trends Immunol.
[12]:624-32
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[12] Parkman R.[1989] Graft-versus-host disease: an alternative hypothesis. Immunol Today.
10[11]:362-4.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[13] Ferrara JL, Cooke KR, Teshima T. [2003] The pathophysiology of acute graft-versus-host
disease. nt J Hematol.78[3]:181-7.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[14] Tawara I, Maeda Y, Sun Y, Lowler KP, Liu C, Toubai T, McKenzie AN, Reddy P. [2008]
Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graftvs-
host disease. Exp Hematol. 36[8]:988-96
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[15] Blazar BR, Murphy WJ. [2005] Bone marrow transplantation and approaches to avoid graftversus-
host disease [GVHD]. Philos Trans R Soc Lond B Biol Sci. 360[1461]:1747-67
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[16] Reddy P. [2003] Pathophysiology of acute graft-versus-host disease. Hematol Oncol.
21[4]:149-61.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[17] Nogueira-Martins MF, Mariano M.[2009] B-1 cell participation in T-cell-mediated alloimmune
response. Immunobiology. [Epub ahead of print]
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[18] Ikehara S.[2000] Pluripotent hemopoietic stem cells in mice and humans. Proc Soc Exp Biol
Med. 223[2]:149-55.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[19] Ikehara S.[2001] Successful allogeneic bone marrow transplantation. Crucial roles of stromal
cells in prevention of graft rejection. Acta Haematol. 105[3]:172-8.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[20] Nasef A, Zhang YZ, Mazurier C, Bouchet S, Bensidhoum M, Francois S, Gorin NC, Lopez
M, Thierry D, Fouillard L, Chapel A.[2009] Selected Stro-1-enriched bone marrow stromal
cells display a major suppressive effect on lymphocyte proliferation. Int J Lab
Hematol31[1]:9-19
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[21] Murphy B, Yu J, Jiao Q, Lin M, Chitnis T, Sayegh MH.[2003] A novel mechanism for the
immunomodulatory functions of class II MHC-derived peptides. J Am Soc Nephrol.
14[4]:1053-65.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[22] Petersen SL.[2007] Alloreactivity as therapeutic principle in the treatment of hematologic
malignancies Studies of clinical and immunologic aspects of allogeneic hematopoietic cell
transplantation with nonmyeloablative conditioning. Dan Med Bull. 54[2]:112-39
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[23] Capitini CM, Herby S, Milliron M, Anver MR, Mackall CL, Fry TJ.[2009] Bone marrow
deficient in IFN-{gamma} signaling selectively reverses GVHD-associated
immunosuppression and enhances a tumor-specific GVT effect. Blood. 113[20]:5002-9.
Epub 2009 Mar 3.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[24] Overes IM, Fredrix H, Kester MG, Falkenburg JH, van der Voort R, de Witte TM, Dolstra
H.[2009] Efficient activation of LRH-1-specific CD8+ T-cell responses from transplanted
leukemia patients by stimulation with P2X5 mRNA-electroporated dendritic cells. J
Immunother. ;32[6]:539-51
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[25] Rezvani AR, Storb RF. [2008] Separation of graft-vs.-tumor effects from graft-vs.-host
disease in allogeneic hematopoietic cell transplantation. J Autoimmun; 30[3]:172-9.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[26] Lu Y, Waller EK.[2009] Dichotomous role of interferon-gamma in allogeneic bone marrow
transplant. Biol Blood Marrow Transplant.15[11]:1347-53
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[27] Kawase T, Matsuo K, Kashiwase K, Inoko H, Saji H, Ogawa S, Kato S, Sasazuki T, Kodera
Y, Morishima Y; Japan Marrow Donor Program.[2009] HLA mismatch combinations
associated with decreased risk of relapse: implications for the molecular mechanism.
Blood.113[12]:2851-8. Epub 2008 Nov 7
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[28] Chakraverty R, Eom HS, Sachs J, Buchli J, Cotter P, Hsu R, Zhao G, Sykes M. [2006] Host
MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated
graft-versus-leukemia responses following delayed donor leukocyte infusions. Blood
108[6]:2106-13. Epub 2006 Jun 6.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[29] Nishida T, Hudecek M, Kostic A, Bleakley M, Warren EH, Maloney D, Storb R, Riddell
SR.[2009] Development of tumor-reactive T cells after nonmyeloablative allogeneic
hematopoietic stem cell transplant for chronic lymphocytic leukemia. Clin Cancer
Res.15[14]:4759-68. Epub 2009 Jun 30
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[30] Quintarelli C, Dotti G, De Angelis B, Hoyos V, Mims M, Luciano L, Heslop HE, Rooney CM,
Pane F, Savoldo B.[2008] Cytotoxic T lymphocytes directed to the preferentially
expressed antigen of melanoma [PRAME] target chronic myeloid leukemia.
Blood.112[5]:1876-85. Epub 2008 Jun 30
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[31] Akatsuka Y, Morishima Y, Kuzushima K, Kodera Y, Takahashi T.[2007] Minor
histocompatibility antigens as targets for immunotherapy using allogeneic immune
reactions. Cancer Sci. 98[8]:1139-46. Epub 2007 May 22
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[32] Spierings E, Hendriks M, Absi L, Canossi A, Chhaya S, Crowley J, Dolstra H, Eliaou JF, Ellis
T, Enczmann J, Fasano ME, Gervais T, Gorodezky C, Kircher B, Laurin D, Leffell MS, Loiseau P, Malkki M, Markiewicz M, Martinetti M, Maruya E, Mehra N, Oguz F,
Oudshoorn M, Pereira N, Rani R, Sergeant R, Thomson J, Tran TH, Turpeinen H, Yang
KL, Zunec R, Carrington M, de Knijff P, Goulmy E. [2007]Phenotype frequencies of
autosomal minor histocompatibility antigens display significant differences among
populations. PLoS Genet.;3[6]:e103.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[33] Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC.[2008] Oral graft-versus-host
disease. Oral Dis. ;14[5]:396-412
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[34] Goulmy E.[2006] Minor histocompatibility antigens: from transplantation problems to therapy
of cancer. Hum Immunol. ;67[6]:433-8. Epub 2006 Apr 6. Review
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[35] Ruggeri L, Capanni M, Mancusi A, Urbani E, Perruccio K, Burchielli E, Tosti A, Topini F,
Aversa F, Martelli MF, Velardi A.[2004] Alloreactive natural killer cells in mismatched
hematopoietic stem cell transplantation. Blood Cells Mol Dis. 33[3]:216-21
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[36] Bensa JC[2003]. The major histocompatibility complex as self-referential. Transfus Clin Biol.
[3]:209-13.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[37] Kolb HJ, Schmid C, Barrett AJ, Schendel DJ[2004]. Graft-versus-leukemia reactions in
allogeneic chimeras. Blood. ;103[3]:767-76
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[38] Zhao XY, Huang XJ.[2007] [Influence factors of reconstitution of killer cell immunoglobulinlike
receptor on NK cells following non-T-cell-depleted haploidentical hematopoietic stem
cell transplantation] Zhonghua Xue Ye Xue Za Zhi. 8[2]:103-6. Chinese
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[39] Parham P, McQueen KL.[2003] Alloreactive killer cells: hindrance and help for
haematopoietic transplants. Nat Rev Immunol. 3[2]:108-22
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[40] Shaulov A, Yue S, Wang R, Joyce RM, Balk SP, Kim HT, Avigan DE, Uhl L, Sackstein R,
Exley MA.[2008] Peripheral blood progenitor cell product contains Th1-biased
noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival.
Exp Hematol. 36[4]:464-72. Epub 2008
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[41] Fujii S.[2005] Application of natural killer T-cells to posttransplantation immunotherapy. Int J
Hematol. 81[1]:1-5
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[42] Sanchez-Fueyo A, Sandner S, Habicht A, Mariat C, Kenny J, Degauque N, Zheng XX, Strom
TB, Turka LA, Sayegh MH.[2006] Specificity of CD4+CD25+ regulatory T cell function in
alloimmunity. J Immunol.;176[1]:329-34.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[43] Akasaki Y, Liu G, Chung NH, Ehtesham M, Black KL, Yu JS.[2004] Induction of a CD4+ T
regulatory type 1 response by cyclooxygenase-2-overexpressing glioma. J
Immunol;173[7]:4352-9.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[44] Hall BM, Tran G, Hodgkinson SJ[2009]. Alloantigen specific T regulatory cells in transplant
tolerance. Int Immunopharmacol.;9[5]:570-4. Epub 2009 Jan 29
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[45] Verma ND, Plain KM, Nomura M, Tran GT, Robinson C, Boyd R, Hodgkinson SJ, Hall
BM.[2009] CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent
alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate
pathways of activation by Th1 and Th2 responses. Blood.;113[2]:479-87
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[46] Li AH, Qiu GQ, Gu WY, Ling Y, Weng KZ, Tan Q, Cao XS.[2007] Expression of CD4+
CD25+ regulatory T cells in the patients with acute lymphocytic leukemia] Xi Bao Yu Fen
Zi Mian Yi Xue Za Zhi. 23[5]:439-42
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[47] Cao J, Chen C, Zeng L, Li L, Li Z, Xu K.[2009] Engineered regulatory T cells prevent graftversus-
host disease while sparing the graft-versus-leukemia effect after bone marrow
transplantation. Leuk Res. [Epub ahead of print
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[48] Guillot-Delost M, Cherai M, Hamel Y, Rosenzwajg M, Baillou C, Simonin G, Leclercq V,
Mariotti-Ferrandiz ME, Six A, Bon-Durand V, Maury S, Salomon BL, Cohen JL,
Klatzmann D, Lemoine FM.[2008] Clinical-grade preparation of human natural regulatory
T-cells encoding the thymidine kinase suicide gene as a safety gene. J Gene Med.
10[8]:834-46
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[49] Maeda A. Extracorporeal photochemotherapy.[2009] J Dermatol Sci.;54[3]:150-6.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[50] Akatsuka Y, Morishima Y, Kuzushima K, Kodera Y, Takahashi T[2007] Minor
histocompatibility antigens as targets for immunotherapy using allogeneic immune
reactions. Cancer Sci. ;98[8]:1139-46
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[51] Akatsuka Y, Morishima Y, Kuzushima K, Kodera Y, Takahashi T[2007] Minor
histocompatibility antigens as targets for immunotherapy using allogeneic immune
reactions. Cancer Sci. ;98[8]:1139-46 Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically
affects MHC stability and TCR recognition. Proc Natl Acad Sci U S A. 106[10]:3889-94.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[52] Hambach L, Ling KW, Pool J, Aghai Z, Blokland E, Tanke HJ, Bruijn JA, Halfwerk H, van
Boven H, Wieles B, Goulmy E.[2009] Hypomethylating drugs convert HA-1-negative solid
tumors into targets for stem cell-based immunotherapy. Blood. ;113[12]:2715-22
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[53] Di Terlizzi S, Zino E, Mazzi B, Magnani C, Tresoldi C, Perna SK, Bregni M, Rossini S, Ciceri
F, Bordignon C, Bonini C, Fleischhauer K.[2006] Therapeutic and diagnostic applications
of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic
stem cell transplantation: a survey of different populations Biol Blood Marrow Transplant.
12[1]:95-101
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[54] Meunier MC, Baron C, Perreault C[2009] Two host factors regulate persistence of H7-
specific T cells injected in tumor-bearing mice. PLoS One. ;4[1]:e4116
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[55] Overes IM, de Rijke B, van Horssen-Zoetbrood A, Fredrix H, de Graaf AO, Jansen JH, van
Krieken JH, Raymakers RA, van der Voort R, de Witte TM, Dolstra H.[2008] Expression
of P2X5 in lymphoid malignancies results in LRH-1-specific cytotoxic T-cell-mediated
lysis. Br J Haematol. 141[6]:799-807
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[56] Spierings E, Goulmy E.[2005] Expanding the immunotherapeutic potential of minor
histocompatibility antigens. J Clin Invest.115[12]:3397-400
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[57] Stumpf AN, van der Meijden ED, van Bergen CA, Willemze R, Falkenburg JH, Griffioen M.
[2009]Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as
hematopoietic targets in antitumor immunity. Blood.;114[17]:3684-92.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[58] Leo Luznik, MD, and Ephraim J. Fuchs, MD[2002] Donor Lymphocyte Infusions to Treat
Hematologic Malignancies in Relapse After Allogeneic Blood or Marrow Transplantation.
Cancer Control, Vol. 9, No.2
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[59] Tomblyn M, Lazarus HM.[2008] Donor lymphocyte infusions: the long and winding road: how
should it be traveled? Bone Marrow Transplant.;42[9]:569-79
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[60] Frey NV, Porter DL. [2008] Graft-versus-host disease after donor leukocyte infusions:
presentation and management. Best Pract Res Clin Haematol. ;21[2]:205-22
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[61] Fowler DH, Gress RE.[2000] Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft
rejection: considerations for the allogeneic transplantation therapy of leukemia and
lymphoma. Leuk Lymphoma. ;38[3-4]:221-34
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[62] Xia G, Truitt RL, Johnson BD.[2006] Graft-versus-leukemia and graft-versus-host reactions
after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and
regulated by regulatory T cells in early and long-term chimeras. Biol Blood Marrow
Transplant. ;12[4]:397-407.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[63] Ge X, Brown J, Sykes M, Boussiotis VA.[2008] CD134-allodepletion allows selective
elimination of alloreactive human T cells without loss of virus-specific and leukemiaspecific
effectors. Biol Blood Marrow Transplant. 14[5]:518-30.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[64] Heslop HE, Stevenson FK, Molldrem JJ.[2003] Immunotherapy of hematologic malignancy.
Hematology Am Soc Hematol Educ Program. :331-49
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[65] Tey SK, Dotti G, Rooney CM, Heslop HE, Brenner MK[2007]. Inducible caspase 9 suicide
gene to improve the safety of allodepleted T cells after haploidentical stem cell
transplantation. Biol Blood Marrow Transplant. 13[8]:913-24
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[66] Perruccio K, Topini F, Tosti A, Carotti A, Aloisi T, Aversa F, Martelli MF, Velardi A
.[2008]Photodynamic purging of alloreactive T cells for adoptive immunotherapy after
haploidentical stem cell transplantation. Blood Cells Mol Dis. ;40[1]:76-83
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[67] Li YL, Wu YG, Wang YQ, Li Z, Wang RC, Wang L, Zhang YY.[2008] Bone marrow-derived
dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric
cancer ex vivo. World J Gastroenterol.;14[46]:7127-32
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[68] Kaneno R, Shurin GV, Tourkova IL, Shurin MR[2009]. Chemomodulation of human dendritic
cell function by antineoplastic agents in low noncytotoxic concentrations. J Transl
Med.;7:58
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[69] Wilde S, Sommermeyer D, Frankenberger B, Schiemann M, Milosevic S, Spranger S, Pohla
H, Uckert W, Busch DH, Schendel DJ.[2009] Dendritic cells pulsed with RNA encoding
allogeneic MHC and antigen induce T cells with superior antitumor activity and higher
TCR functional avidity. Blood.;114[10]:2131-9.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[70] Gregori S, Magnani CF, Roncarolo MG. Role of human leukocyte antigen-G in the induction
of adaptive type 1 regulatory T cells Hum Immunol. 2009 Dec;70[12]:966-9
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[71] Hadeiba H, Sato T, Habtezion A, Oderup C, Pan J, Butcher EC[2008]. CCR9 expression
defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host
disease. Nat Immunol. 9[11]:1253-60
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[72] Cao DY, Yang JY, Yue SQ, Tao KS, Song ZS, Wang DS, Yang YL, Dou KF.
[2009] Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell
line HepG2 and autologous tumor cells as potential cancer vaccines against
hepatocellular carcinoma. Cell Immunol.;259[1]:13-20
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[73] Alpdogan O, Schmaltz C, Muriglan SJ, Kappel BJ, Perales MA, Rotolo JA, Halm JA, Rich
BE, van den Brink MR. Administration of interleukin-7 after allogeneic bone marrow
transplantation improves immune reconstitution without aggravating graft-versus-host
disease. Blood. 2001 Oct 1;98[7]:2256-65
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[74] Banovic T, MacDonald KP, Markey KA, Morris ES, Kuns RD, Varelias A, Hill
GR.[2009]Donor treatment with a multipegylated G-CSF maximizes graft-versusleukemia
effects. Biol Blood Marrow Transplant.15[1]:126-30
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[75] Teshima T, Hill GR, Pan L, Brinson YS, van den Brink MR, Cooke KR, Ferrara JL. [1999]L-
11 separates graft-versus-leukemia effects from graft-versus-host disease after bone
marrow transplantation J Clin Invest. ;104[3]:317-25
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[76] Zheng YX, Hou GH, Song J, Zhang C, Liang T.[2007] Effect of Rapamycin on CD4[+]
CD25[+] regulatory T cells in allo-transplantation tolerance model. Xi Bao Yu Fen Zi Mian
Yi Xue Za Zhi. ;23[4]:327-30
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[77] Buckland M, Jago C, Fazekesova H, George A, Lechler R, Lombardi G.[2006] Aspirin
modified dendritic cells are potent inducers of allo-specific regulatory T-cells. Int
Immunopharmacol. ;6[13-14]:1895-901.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[78] Buckland M, Lombardi G.[2009] Aspirin and the induction of tolerance by dendritic cells.
Handb Exp Pharmacol. ;[188]:197-213.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[79] Mitchell MS.[2002] Cancer vaccines, a critical review--Part I. Curr Opin Investig
Drugs.;3[1]:140-9
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[80] Ho VT, Vanneman M, Kim H, Sasada T, Kang YJ, Pasek M, Cutler C, Koreth J, Alyea E,
Sarantopoulos S, Antin JH, Ritz J, Canning C, Kutok J, Mihm MC, Dranoff G, Soiffer
R.[2009] Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell
vaccines early after allogeneic stem cell transplantation. Proc Natl Acad Sci U S
A.;106[37]:15825-30
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[81] Jenq RR, King CG, Volk C, Suh D, Smith OM, Rao UK, Yim NL, Holland AM, Lu SX,
Zakrzewski JL, Goldberg GL, Diab A, Alpdogan O, Penack O, Na IK, Kappel LW,
Wolchok JD, Houghton AN, Perales MA, van den Brink MR. [2009]Keratinocyte growth
factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone
marrow transplantation Blood.;113[7]:1574-80
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[82] Nizar Habal, MD, Rishab K. Gupta, PhD, Anton J. Bilchik, MD, PhD, Reynold Yee, BS,
Zacharias Leopoldo, DDM, Wei Ye, MS, Robert M. Elashoff, PhD and Donald L. Morton,
MD.[2001] CancerVax, An Allogeneic Tumor Cell Vaccine, Induces Specific Humoral and
Cellular Immune Responses in Advanced Colon Cancer. Annals of Surgical Oncology
8:389-401
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[83] Pallandre JR, Brillard E, Créhange G, Radlovic A, Remy-Martin JP, Saas P, Rohrlich PS,
Pivot X, Ling X, Tiberghien P, Borg C.[2007] Role of STAT3 in CD4+CD25+FOXP3+
regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor
immunity. J Immunol.;179[11]:7593-604
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[84] Stangl S, Gross C, Pockley AG, Asea AA, Multhoff G.[2008] Influence of Hsp70 and HLA-E
on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer
[NK] cells. Cell Stress Chaperones. 13[2]:221-30
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[85] van Luijn MM, Chamuleau ME, Thompson JA, Ostrand-Rosenberg S, Westers TM, Souwer
Y, Ossenkoppele GJ, van Ham SM, van de Loosdrecht AA.[2009] CLIP down-modulation
enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T
cell responses. Haematologica. 2009 Nov 10.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[86] Lin SJ, Yan DC, Lee YC, Kuo ML.[2008] Role of interleukin-15 in umbilical cord blood
transplantation. Int Rev Immunol.;27[6]:518-31
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[87] Tanaka J, Sugita J, Kato N, Toubai T, Ibata M, Shono Y, Ota S, Kondo T, Kobayashi T,
Kobayashi M, Asaka M, Imamura M.[2007] Expansion of natural killer cell receptor
[CD94/NKG2A]-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from
the same cord blood unit. Exp Hematol. ;35[10]:1562-6
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[88] Verneris MR, Brunstein CG, Barker J, MacMillan ML, DeFor T, McKenna DH, Burke MJ,
Blazar BR, Miller JS, McGlave PB, Weisdorf DJ, Wagner JE[2009]. Relapse risk after
umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients
of 2 units. Blood.;114[19]:4293-9.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[89] Willemze R, Rodrigues CA, Labopin M, Sanz G, Michel G, Socié G, Rio B, Sirvent A,
Renaud M, Madero L, Mohty M, Ferra C, Garnier F, Loiseau P, Garcia J, Lecchi L, Kögler
G, Beguin Y, Navarrete C, Devos T, Ionescu I, Boudjedir K, Herr AL, Gluckman E, Rocha
V; Eurocord-Netcord and Acute Leukaemia Working Party of the EBMT[2009]. KIR-ligand
incompatibility in the graft-versus-host direction improves outcomes after umbilical cord
blood transplantation for acute leukemia. Leukemia. 23[3]:492-500
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[90] Vago L, Perna SK, Zanussi M, Mazzi B, Barlassina C, Stanghellini MT, Perrelli NF,
Cosentino C, Torri F, Angius A, Forno B, Casucci M, Bernardi M, Peccatori J, Corti C,
Bondanza A, Ferrari M, Rossini S, Roncarolo MG, Bordignon C, Bonini C, Ciceri F,
Fleischhauer K.[2009] Loss of mismatched HLA in leukemia after stem-cell
transplantation. N Engl J Med.;361[5]:478-88
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[91] Elsner HA, Blasczyk R.[2004] Immunogenetics of HLA null alleles: implications for blood
stem cell transplantation. Tissue Antigens.;64[6]:687-95
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[92] Sun Y, Kong F, Ren S, Yuan F, Liang F, Liu N, Jin L, Xi Y[2007]. Severe acute graft-vs-host
disease in a patient with acute monocytic leukemia having a recombination event
between HLA-A/B loci from a multiple recombinant family Tissue Antigens.;70[6]:499-
505.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[93] Worthley DL, Ruszkiewicz A, Davies R, Moore S, Nivison-Smith I, Bik To L, Browett P,
Western R, Durrant S, So J, Young GP, Mullighan CG, Bardy PG, Michael MZ.[2009].
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone
marrow-derived cells following allogeneic stem cell transplantation. Stem
Cells.;27[6]:1463-8
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[94] Brown JA, Boussiotis VA[2008] Umbilical cord blood transplantation: basic biology and
clinical challenges to immune reconstitution. Clin Immunol. 127[3]:286-97
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[95] Morris ES, MacDonald KP, Hill GR[2006] Stem cell mobilization with G-CSF analogs: a
rational approach to separate GVHD and GVL? Blood.;107[9]:3430-5
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[96] Foley JE, Mariotti J, Ryan K, Eckhaus M, Fowler DH.[2008] Th2 cell therapy of established
acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or hosttype
antigen-presenting cells. Biol Blood Marrow Transplant.;14[9]:959-72
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[97] Afzali B, Lombardi G, Lechler RI.[2008] Pathways of major histocompatibility complex
allorecognition. Curr Opin Organ Transplant.;13[4]:438-44
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[98] Joseph Pidala and Claudio Anasetti.[2009] Can antigen-specific regulatory T cells protect
against graft vs. host disease and spare anti-malignancy alloresponse? Haematologica..
[Epub ahead of print]
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[99] Rowe V, Banovic T, MacDonald KP, Kuns R, Don AL, Morris ES, Burman AC, Bofinger HM,
Clouston AD, Hill GR.[2006] Host B cells produce IL-10 following TBI and attenuate acute
GVHD after allogeneic bone marrow transplantation. Blood.;108[7]:2485-92
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[100] Shimizu H, Nukui Y, Mitsuhashi N, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Miyazaki
M.[2009] Induction of antitumor response by in vivo allogeneic major histocompatibility
complex gene transfer using electroporation. J Surg Res;154[1]:60-7
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[101] Perruccio K, Tosti A, Burchielli E, Topini F, Ruggeri L, Carotti A, Capanni M, Urbani E,
Mancusi A, Aversa F, Martelli MF, Romani L, Velardi A. [2005]Transferring functional
immune responses to pathogens after haploidentical hematopoietic transplantation.
Blood.;106[13]:4397-406.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus
[102] Spierings E.[2008] Minor histocompatibility antigens: targets for tumour therapy and
transplant tolerance. Int J Immunogenet [4-5]:363-6.
» CrossRef » Google Scholar » PubMed » DOAJ » CAS » Scopus